By connectivity mapping, we have identified sulpiride as one of the potential small molecules that could reverse DAPK1 and its co-regulated genes expression pattern in liver cancer, which may have potential therapeutic value in liver cancer, especially for those with reduced DAPK1 expression. This evidence concerns the gene DAPK1 and liver cancer.